Us Fda
May 28, 2012 at 14:41 | Source: Moneycontrol.com
May 28, 2012 at 14:34 | Source: Moneycontrol.com
May 23, 2012 at 12:21 | Source: Moneycontrol.com
May 18, 2012 at 12:58 | Source: Moneycontrol.com
May 16, 2012 at 12:24 | Source: Moneycontrol.com
May 11, 2012 at 09:45 | Source: Moneycontrol.com
Videos »
Photos »
/ 
News across the web »
May 26, 2012 at 22:27 | Source: The Hindu BusinessLine
May 25, 2012 at 22:26 | Source: FirstPost
May 24, 2012 at 10:06 | Source: DNA India
May 19, 2012 at 04:56 | Source: FirstPost
May 18, 2012 at 12:06 | Source: FirstPost
Interact & exchange stock tips & market info »
Related News »
Ranbaxy Laboratories' US based subsidiary Ranbaxy Laboratories Inc., (RLI) has received US FDA approval for Absorica, a novel, patented brand formulation of the acne medication isotretinoin, developed by Cipher, for the treatment of severe recalcitrant ...
May 28, 2012 at 10:24 | Source: pharmabiz.com
WASHINGTON May 22 (Reuters) - U.S. drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease. The U.S. Food and Drug Administration staff reviewed ...
May 22, 2012 at 14:27 | Source: Reuters
The United States Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee has found Pfizer’s clinical data package for tafamidis meglumine. Tafamidis is a novel, investigational, oral therapy for the ...
May 26, 2012 at 05:11 | Source: pharmabiz.com
Ranbaxy Laboratories has got US FDA nod for Cipher Isotretinoin NDA, reports CNBC-TV18. It touched an intraday high of Rs 537.00 and an intraday low of Rs 523.95. At 14:38 hrs the share was quoting at Rs 530.00, down Rs 0.30, or 0.06%.
May 28, 2012 at 08:58 | Source: MoneyControl.com
The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters perceptions that the drug ...
May 15, 2012 at 23:54 | Source: EurekAlert
WASHINGTON, May 21 (Reuters) - U.S. drug reviewers said Johnson & Johnson's (Symbol : JNJ) blood thinner Xarelto appeared to reduce the risk of new heart attacks and strokes in people with heart problems, but missing data raised doubts about whether the ...
May 21, 2012 at 13:09 | Source: Inside Fidelity
WASHINGTON (Reuters) - U.S. drug reviewers asked advisers to consider if Arena Pharmaceuticals' obesity pill lorcaserin raised the risk of tumors and heart problems. Lorcaserin is one of three new potential obesity treatments vying for approval ...
May 8, 2012 at 13:10 | Source: msnbc.com
(RTTNews) - Medgenics Inc (MDGN: News ) Thursday announced that the U.S Food and Drug Administration or the FDA granted its consent to the company to proceed with a Phase IIb clinical trial of EPODURE for the treatment of anemia in patients undergoing ...
May 17, 2012 at 14:40 | Source: RTT News
Aurobindo Pharma on Wednesday said its tentatively approved abbreviated new drug applications for Nevirapine Tablets 200mg and Nevirapine oral suspension have received final approval from US Food and Drug Administration (FDA). Aurobindo's ...
May 23, 2012 at 08:06 | Source: MoneyControl.com
WASHINGTON, May 22 (Reuters) - U.S. drug reviewers recommended on Tuesday rejecting a Pfizer Inc (Symbol : PFE) drug because the data did not prove it worked well in treating a rare neurodegenerative disease. The U.S. Food and Drug Administration staff ...
May 22, 2012 at 13:51 | Source: Inside Fidelity